EUVIMEDEUVIMED entdecken
Studienprotokoll

New Benchmarks on Protocol Amendment Experience in Oncology Clinical Trials

Emily Botto iD, Zachary Smith, Kenneth Getz

Therapeutic Innovation & Regulatory Science · 2024

DOI: 10.1007/s43441-024-00629-2 ↗

Kurz gefasst

Studienprotokoll in der Zeitschrift Therapeutic Innovation & Regulatory Science, 2024. Verfasst von Emily Botto und 2 weiteren Autor:innen. Beteiligte Einrichtung: Tufts University School of Medicine, 145 Harrison Ave, Boston, MA, 02111, USA. Emily.botto@tufts.edu. Hauptthemen laut MEDLINE: Clinical Trials as Topic, Benchmarking. Die Arbeit nennt 21 Literaturangaben. Gefördert von: Gilead Sciences, Biogen Idec, EMD Serono.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Clinical Trials as TopicBenchmarkingHumansNeoplasmsCOVID-19Medical OncologyDrug IndustryDrug DevelopmentResearch DesignClinical Trial Protocols as Topic

Stichwörter der Autor:innen

OncologyProtocol amendmentsProtocol complexityProtocol designProtocol design changes

Autor:innen und Institutionen

  • Tufts University School of Medicine, 145 Harrison Ave, Boston, MA, 02111, USA. Emily.botto@tufts.edu.
  • Tufts University School of Medicine, 145 Harrison Ave, Boston, MA, 02111, USA.

ORCID-Profile: Emily Botto

Förderung

  • Gilead Sciences
  • Biogen Idec
  • EMD Serono
  • Amgen
  • Merck
  • Eli Lilly and Company
  • AstraZeneca
  • Regeneron Pharmaceuticals

Zitieren

APA

Botto, E., Smith, Z., & Getz, K. (2024). New Benchmarks on Protocol Amendment Experience in Oncology Clinical Trials. Therapeutic Innovation & Regulatory Science. https://doi.org/10.1007/s43441-024-00629-2

Vancouver

Botto E, Smith Z, Getz K. New Benchmarks on Protocol Amendment Experience in Oncology Clinical Trials. Therapeutic Innovation & Regulatory Science. 2024. doi:10.1007/s43441-024-00629-2

BibTeX
@article{Botto2024,
  author = {Botto, Emily and Smith, Zachary and Getz, Kenneth},
  title = {New Benchmarks on Protocol Amendment Experience in Oncology Clinical Trials},
  journal = {Therapeutic Innovation & Regulatory Science},
  year = {2024},
  doi = {10.1007/s43441-024-00629-2}
}
Kostenlos starten →